Nachrichten zur Merck KGaA Aktie

Merck Buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Merck KGaA nach Zahlen von 158 auf…

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a…

ROUNDUP 2/Schwacher Dollar: Merck verfehlt Erwartungen - Neue Prognose

(neu: Aussagen aus der Pressekonferenz, Details, Analyst, Aktienkurs) DARMSTADT (dpa-AFX) - Die Dollar-Schwäche hat dem Merck-Konzern …

ROUNDUP 2/Schwacher Dollar: Merck verfehlt Erwartungen - Neue Prognose

(neu: Aussagen aus der Pressekonferenz, Details, Analyst, Aktienkurs) DARMSTADT (dpa-AFX) - Die Dollar-Schwäche…

ROUNDUP/Schwacher Dollar: Merck verfehlt Erwartungen - Neue Prognose

DARMSTADT (dpa-AFX) - Die Dollar-Schwäche hat dem Merck-Konzern ein unerwartet schwaches zweites Quartal eingebrockt. Zwar…

ROUNDUP/Schwacher Dollar: Merck verfehlt Erwartungen - Neue Prognose

DARMSTADT (dpa-AFX) - Die Dollar-Schwäche hat dem Merck-Konzern ein unerwartet schwaches zweites Quartal eingebrockt. Zwar konnten die Darmstädter organisch…

AKTIE IM FOKUS: Schwache Elektroniksparte setzt Merck-Kurs unter Druck

FRANKFURT (dpa-AFX) - Eine schwache Elektroniksparte der Merck KGaA im zweiten Quartal hat am Donnerstag…

Pharmabranche: Währungseffekte belasten Merck – Prognose erneut gestutzt

Der deutsche Pharmakonzern verpasst beim operativen Ergebnis die Erwartungen. Und auch der Ausblick fällt trüb aus. Dabei wachsen die zwei…

Merck KGaA lifts 2025 profit outlook after strong drug, AI material sales in Q2 By Investing.com

Merck KGaA lifts 2025 profit outlook after strong drug, AI material sales in Q2…

Schwacher Dollar: Umsatz- und Ergebniseinbußen für Merck - Nochmals neue Ziele

DARMSTADT (dpa-AFX) - Die Dollar-Schwäche hat beim Darmstädter Merck-Konzern für ein unerwartet schwaches zweites Quartal…

Schwacher Dollar: Umsatz- und Ergebniseinbußen für Merck - Nochmals neue Ziele

DARMSTADT (dpa-AFX) - Die Dollar-Schwäche hat beim Darmstädter Merck-Konzern für ein unerwartet schwaches zweites Quartal gesorgt. Der Umsatz ging um…

Exelixis EXEL Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATEMonday, July 28, 2025 at 9:00 p.m. ETCALL PARTICIPANTSPresident & CEO — Michael M. MorrisseyChief Financial…

Opko Health (OPK) Q2 Revenue Falls 14%

Key PointsRevenue (GAAP) missed expectations, falling to $156.8 million in Q2 2025—down approximately 14% from the prior year quarter and…

Merck Market-Perform

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Merck KGaA auf "Market-Perform" mit einem Kursziel…

Bernstein belässt Merck KGaA auf Market-Perform - Ziel 147 Euro

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Merck KGaA auf "Market-Perform" mit einem Kursziel…

Global New Material International schließt transformative Übernahme des Surface-Solutions-Geschäfts von Merck ab und beschleunigt damit seine globale Expansion

Global New Material International Holdings Limited: Frankfurt (ots/PRNewswire) - Global New Material International Holdings Limited („GNMI" oder „die Gruppe") (6616.HK),…

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.…

Merck Stock Is Almost A Classical Benjamin Graham Investment

…

Merck extends pause on China Gardasil shipments to year end, shares slip

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of…

Merck to extend pause on China Gardasil shipments to year end

Merck & Co said on Tuesday it was extending its hold on Gardasil shipments to China until at least the…

Merck Stock Falls After Layoff Announcement, Gardasil Sales Drop

Merck stock fell early Tuesday after Q2 results. The Dow Jones drugmaker plans for job cuts as part of restructuring…

Merck Posts Q2 EPS Beat Revenue Slips

Key Points- Non-GAAP EPS of $2.13 topped estimates by $0.11 in Q2 2025; GAAP revenue of $15.8 billion missed by…

Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook

The multi-year effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster cancer…

Merck to cut jobs and costs as demand for Gardasil in China remains weak By Reuters

Merck to cut jobs and costs as demand for Gardasil in China remains weak…

Merck posts Q2 earnings miss, unveils cost-cutting initiative

Merck & Co Inc (NYSE:MRK, ETR:6MK) shares moved lower in early trade as the pharmaceutical company reported second quarter earnings…

Merck Q2 Earnings Top, Sales Meet Estimates, 2025 View Narrowed

MRK beats second-quarter estimates for EPS while matching the same for sales. The company trims its 2025 outlook.…

Bernstein belässt Merck KGaA auf Market-Perform - Ziel 147 Euro

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Merck KGaA auf "Market-Perform" mit einem Kursziel…

The Best High-Yield Dividend ETF to Own for the Next 10 Years

Key PointsCompanies must pass key tests to be included in the Schwab U.S. Dividend Equity ETF.This fund has averaged a…

U.S. Biomarkers Market Forecast 2025-2034 Featuring Analysis of Roche, Merck, Thermo Fisher Scientific, QIAGEN and Other Industry Leaders

Key growth drivers include rising demands for high-sensitivity diagnostics and personalized medicine, advancements in genomics, proteomics, and AI-driven innovations, and…

This Healthcare Stocks Revolutionary Drug Could Make Early Investors Rich

Key PointsSummit Therapeutics leading candidate is showing promise in a key oncology market.The medicine could earn plenty of indications across…

3 Monster Stocks in the Making to Buy Right Now

Key PointsCRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential remaining.Viking Therapeutics is targeting…

Does This Move Make Merck Stock a Buy?

Key PointsMerck is seeking ways to prepare for a significant upcoming patent cliff.The company has just announced another acquisition that…

Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?

Key PointsPfizer stands as one of the largest pharmaceutical companies in the world.Although it has an attractive 7.1% yield, it…

Want Decades of Passive Income? Buy This ETF and Hold It Forever

Key PointsThe Schwab U.S. Dividend Equity ETF is a passive income machine.This ETF is also attractively valued and has delivered…

Merck (MRK) Falls More Steeply Than Broader Market: What Investors Need to Know

In the closing of the recent trading day, Merck (MRK) stood at $79.96, denoting a -1.91% move from the preceding…

NACHBÖRSE/XDAX -0,4% auf 24.191 Pkt - Merck mit bedingter EU-Zulassung für Ezmekly

DJ NACHBÖRSE/XDAX -0,4% auf 24.191 Pkt - Merck mit bedingter EU-Zulassung für Ezmekly DOW JONES--Die Merck KGaA hat eine bedingte…

NACHBÖRSE/XDAX -0,4% auf 24.191 Pkt - Merck mit bedingter EU-Zulassung für Ezmekly

DOW JONES--Die Merck KGaA hat eine bedingte Zulassung für die Vermarktung des Medikaments Ezmekly in der EU erhalten. Wie der…

Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?

LLYs explosive growth from Mounjaro and Zepbound outpaces MRKs Keytruda-led gains, despite valuation concerns.…

Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business

Key PointsMerck aims to boost its business by buying Verona Pharma for $10 billion.Through the deal, it will add Ohtuvayre…

Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business @themotleyfool #stocks $MRK $VRNA

…

Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

Merck (MRK) Falls More Steeply Than Broader Market: What Investors Need to Know

In the closing of the recent trading day, Merck (MRK) stood at $81.52, denoting a -2.57% move from the preceding…

Is SCHD Good For Retirees?

Key PointsPros for the Schwab U.S. Dividend Equity ETF include a high yield, impressive dividend growth, and low costs.Cons include…

Diese drei Dow-Aktien locken mit starker Dividendenrendite

• Verizon mit hoher Rendite und starker Cash-Generierung• Chevron steigert Dividende seit Jahrzehnten• Merck punktet mit starker Pipeline Dividenden …

The Zacks Analyst Blog Highlights Microsoft, Alibaba Group, Merck, Monarch Cement and Team

MSFT, BABA, and MRK headline todays top analyst picks, with AI, global e-commerce, and oncology driving mixed growth stories.…

Key deals this week: Meta, Boyd Gaming, Merck, Sandstorm Gold, Capgemini and more

…

Motley Fool CEO Tom Gardner: S&P 500 (VOO) at 25× Earnings Is Stretching Valuations

Key PointsMotley Fool CEO Tom Gardner is worried that the "market" is a bit stretched valuation-wise.Gardner thinks there are still…

Biotech-Übernahmekarussell nimmt Fahrt auf! BioNTech, Evotec, Merck, BioNxt Solutions Aktie!

Das Übernahmekarussell dreht sich im Biotech-Sektor wieder schneller. Jüngstes Beispiel ist die Übernahme von Verona Pharma durch Merck. Der US-Konzern…

Mercks VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?

MRKs $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.…

Merck (MRK) Rises Higher Than Market: Key Facts

Merck (MRK) closed the most recent trading day at $83.71, moving +2.88% from the previous trading session.…